Articles Referencing ANDA
Actavis Challenges Patents - Analyst Blog
6/10/2013, 11:50 am from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) recently
announced that it is seeking FDA approval for its generic versions
of Fresenius Kabi's Diprivan and Bayer's ( BAYRY ) Safyral.
While Diprivan is an... Read >>
Shire Settles Lawsuit with Teva - Analyst Blog
6/3/2013, 5:26 pm from Zacks.com in Investing, Business, Stocks
Shire LLC ( SHPG ) recently
announced the settlement of its patent infringement lawsuit against
Teva Pharmaceuticals ( TEVA ) for Shire's
attention deficit hyperactivity disorder (ADHD)... Read >>
Patent Challenge from Perrigo - Analyst Blog
5/31/2013, 6:28 pm from Zacks.com in Investing, Business, Stocks
Perrigo Company ( PRGO ) recently
announced that it is seeking US approval to market its generic
version of Eli Lilly and Company 's ( LLY ) Axiron. The drug
is marketed for treating... Read >>
Generic Launches at Mylan Continue - Analyst Blog
5/22/2013, 3:27 pm from Zacks.com in Investing, Business, Stocks
Mylan Inc. ( MYL ) recently
announced the launch of its generic version of AbbVie
Inc. 's ( ABBV ) cholesterol
management drug, TriCor (fenofibrate, 48 mg and 145 mg tablets).
Mylan... Read >>
Loss Widens at Momenta - Analyst Blog
5/2/2013, 9:57 am from Zacks.com in Investing, Business, Stocks
Momenta Pharmaceuticals Inc. ( MNTA ) reported first
quarter 2013 net loss per share of 48 cents, wider than the Zacks
Consensus Estimate of a loss of 43 cents and the year-ago loss of
10... Read >>
Setback for Valeant Pharma - Analyst Blog
4/5/2013, 1:09 pm from Zacks.com in Investing, Business, Stocks
Valeant Pharmaceuticals International, Inc. (
VRX ) recently
stated that it anticipates its 2013 guidance to decline following
the approval of a generic version of its... Read >>
Dr. Reddy's Launches Generic Reclast - Analyst Blog
4/4/2013, 7:06 pm from Zacks.com in Investing, Business, Stocks
Dr. Reddy's Laboratories Ltd. ( RDY ) recently
announced the launch of its therapeutic equivalent generic version
of Novartis AG 's ( NVS ) Reclast
(zoledronic acid 5 mg/100 mL)... Read >>
Another Generic Launch at Mylan - Analyst Blog
4/4/2013, 3:09 pm from Zacks.com in Investing, Business, Stocks
Mylan Inc. ( MYL ) recently
announced the launch of its generic version of
Valeant Pharmaceuticals
International 's ( VRX ) Zovirax ointment.
Mylan launched the drug after receiving... Read >>
Dr. Reddy's Launches Generic Accutane - Analyst Blog
4/1/2013, 5:11 pm from Zacks.com in Investing, Business, Stocks
Dr. Reddy's Laboratories Ltd. ( RDY ) recently
announced the launch of Zenatane (isotretinoin) capsules, its
generic version of Hoffman-La Roche Inc.'s acne drug Accutane. The
launch... Read >>
Actavis/AZN Settle Crestor Litigation - Analyst Blog
3/26/2013, 4:24 pm from Zacks.com in Investing, Business, Stocks
Actavis Inc. ( ACT ) recently entered
into a settlement agreement with AstraZeneca ( AZN ) regarding their
patent litigation for Crestor. Actavis was looking to launch its
generic... Read >>
Good News for Mylan's Generic Unit - Analyst Blog
3/20/2013, 1:46 pm from Zacks.com in Investing, Business, Stocks
Recently, Mylan Inc. 's ( MYL ) generic segment
received encouraging news when the US Food and Drug Administration
(FDA) granted final approval to its Abbreviated New Drug
Application... Read >>
Actavis in Patent Challenge - Analyst Blog
3/11/2013, 5:12 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) announced that it
has amended its abbreviated new drug application (ANDA) for its
generic version of Novartis' ( NVS ) Exelon Patch
(rivastigmine transdermal... Read >>
Good News for Pernix Therapeutics - Analyst Blog
3/5/2013, 4:55 pm from Zacks.com in Investing, Business, Stocks
Pernix Therapeutics Holdings, Inc ( PTX ) recently
announced that its subsidiary, Hawthorn Pharmaceuticals, Inc., has
received approval from the US Food and Drug Administration (FDA)
for... Read >>
Actavis Files ANDA for Endo Product - Analyst Blog
3/5/2013, 4:40 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) recently
announced that it is looking to get its generic version of
Endo Health Solutions Inc. 's ( ENDP ) Fortesta
(testosterone gel 10mg/0.5g) approved in the... Read >>
Dr. Reddy's Launches Generic Zometa - Analyst Blog
3/5/2013, 3:40 pm from Zacks.com in Investing, Business, Stocks
Dr. Reddy's Laboratories Ltd. ( RDY ) recently
announced that the launch of its bioequivalent generic version of
Novartis AG 's ( NVS ) Zometa
(zoledronic acid 4 mg/5 mL) Injection in... Read >>